Boston Trust Walden Corp Trims Stock Holdings in CVS Health Co. (NYSE:CVS)

Boston Trust Walden Corp lowered its position in shares of CVS Health Co. (NYSE:CVS) by 84.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,585 shares of the pharmacy operator’s stock after selling 119,121 shares during the quarter. Boston Trust Walden Corp’s holdings in CVS Health were worth $1,275,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of CVS. USA Financial Formulas grew its holdings in CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. purchased a new stake in shares of CVS Health in the 4th quarter worth approximately $32,000. First Community Trust NA increased its position in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares in the last quarter. Creekmur Asset Management LLC bought a new stake in CVS Health in the fourth quarter worth $34,000. Finally, Steph & Co. grew its stake in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent analyst reports. Barclays cut their price objective on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. JPMorgan Chase & Co. reduced their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Cantor Fitzgerald upped their price objective on CVS Health from $58.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, August 8th. Wells Fargo & Company increased their target price on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Finally, Robert W. Baird assumed coverage on CVS Health in a report on Thursday, May 30th. They set a “neutral” rating and a $61.00 price target on the stock. Eleven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $73.24.

CVS Health Stock Up 1.4 %

NYSE CVS opened at $58.35 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock’s 50 day moving average is $59.04 and its 200 day moving average is $65.55. The stock has a market cap of $73.25 billion, a PE ratio of 10.25, a P/E/G ratio of 0.57 and a beta of 0.52.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period last year, the company posted $2.21 earnings per share. Research analysts predict that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.56%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.